One year of duodenal-jejunal bypass liner therapy (Endobarrier (R)) leads to perturbations in the metabolic profile of urine, plasma and stool of obese diabetic patients.

A Ruban, Z Liu, M Glaysher, H Ashrafian, A Miras, C Prechtl, A Goldstone, M Aldhwayan, N Chhina, W Al-Najim, N Johnson, M Patel, J Li, J Byrne, J Teare

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Original languageEnglish
Title of host publicationOBESITY SURGERY
Publication statusPublished (in print/issue) - 1 Mar 2020

Cite this